Metabolomics profiling in prediction of chemo-immunotherapy efficiency in advanced non-small cell lung cancer

BACKGROUND: To explore potential metabolomics biomarker in predicting the efficiency of the chemo-immunotherapy in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 83 eligible patients were assigned to receive chemo-immunotherapy. Serum samples were prospectively collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Lihong, Zhang, Zhihua, Li, Xushuo, Yang, Ying, Qi, Ruixue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887290/
https://www.ncbi.nlm.nih.gov/pubmed/36733356
http://dx.doi.org/10.3389/fonc.2022.1025046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887290/
https://www.ncbi.nlm.nih.gov/pubmed/36733356
http://dx.doi.org/10.3389/fonc.2022.1025046

Ejemplares similares